JOINT PRESS RELEASE
THE HON. TONY ABBOTT MHR, LEADER OF THE OPPOSITION
THE HON. PETER DUTTON MHR, SHADOW MINISTER FOR HEALTH AND AGEING
Thursday 29 November 2012.
A Coalition government will provide $35 million to help find a cure for type 1 diabetes.
Over 122,000 Australians have type 1 diabetes including 20,000 children.
More than 800,000 Australians suffer from both forms of diabetes. Excluding the costs of complications, diabetes costs the Australian health system $1.6 billion annually.
Type 1 diabetes is a life-long auto-immune disease that usually occurs in childhood but can be diagnosed at any age. Type 1 diabetes is one of the most common chronic diseases in children and most newly diagnosed cases are in people less than 15 years old.
Australia has some of the best researchers in the world and a proven record of progress in this difficult area of research.
The Juvenile Diabetes Research Foundation Clinical Research Network (CRN) is a collaboration between researchers, institutions, patients, industry and international networks and it will oversee the investment in this critical research.
A Coalition Government would provide $7 million per year over five years to allow the CRN to fund a significant number of additional patient trials both locally and internationally and a coordinated nationwide approach to diabetes research.
By expanding the CRN’s research capacity, it can become a bigger hub for even more financial support by investors and philanthropists into possible cures.
Australians can be proud of the work of the Juvenile Diabetes Research Foundation (JDRF). In 2006 the Howard Government provided $30 million to the JDRF to establish the Islet Transplantation Programme. This programme has produced real results including the reduction, and sometimes the elimination – of dangerous hypoglycaemic attacks.
The Coalition has long recognised the value of the Foundation which brings together the very best of Australia’s talent to tackling this critical health problem.
Australia is a world leader in this important area of medical research and the Coalition’s commitment will ensure it continues to do so.